Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A) Immunohistochemistry staining of DKK1 in the livers of patients with NAFLD (n = 5) and normal individuals (n = 3); scale bar = 100 µ m, (B) in liver samples from WT mice fed with chow and HFD for 24 wk (n = 5). Scale bar = 100 µ m. (C) qPCR analysis of DKK1 mRNA expression in livers of chow- and HFD-fed 24-wk mice (n = 4 mice for each group). (D, E) Representative Western blot of DKK1 in liver samples of chow- and HFD-fed mice (n = 4). Each lane represents liver lysates from individual mouse. (F) Serum DKK1 protein levels in chow- or HFD-fed mice for 24 wk (n = 15–17). (G) Western blot of DKK1 in different primary cells isolated from HFD-fed mice liver. Hep, hepatocytes; HSC, hepatic stellate cells; LSEC, liver sinusoidal endothelial cells; KC, Kupffer cells. (H) Western blot analysis of DKK1 in AML12 cells under different concentrations of FFA exposures (N = 2). ** P < 0.01 as compared with the indicated controls by two-tailed t tests (two groups). All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Immunohistochemistry, Staining, Expressing, Western Blot, Isolation, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A) Represented images of DKK1 immunohistochemistry staining on liver sections from NAFLD patients (n = 5) and normal controls (n = 3); scale bar = 100 µ m. (B) LW and LW/BW index of chow- and HFD-fed 6-mo mice (n = 5). (C) Lipid accumulations in the livers were analyzed by H&E staining and ORO staining (n = 3); scale bar = 100 µ m. (D, E) Serum ALT, AST; (E) serum lipids measurement (n = 14–17). ** P < 0.01, *** P < 0.001, **** P < 0.0001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Immunohistochemistry, Staining, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A) Schematic illustration of experiment procedure. AAV tail intravenous injection with AAV-GFP-NC (n = 4), AAV-OE-DKK1 (n = 5), or AAV-sh-DKK1 (n = 6) and then fed HFD for 20 wk before euthanasia. (B) Dynamic body weight tracking of chow- and HFD-fed mice with DKK1 manipulations. (C) Representative Western blot of DKK1 in liver samples of HFD-fed mice after 20 wk (n = 3). Each lane represents liver lysates from individual mouse. (D) H&E and ORO staining. Scale bar = 200 µ m; (E, F) lipid contents in liver of mice with different DKK1 gene manipulations under chow or HFD fed (n = 3). (G, H) Serum lipid contents with different DKK1 gene manipulations under chow or HFD fed. (I) The expression confirmations of lipid metabolism–related genes in liver of mice with different DKK1 gene manipulations under chow or HFD fed (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. ns, not significant. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Injection, Western Blot, Staining, Expressing, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A) H&E staining of livers from controls and different DKK1 gene manipulations with 20 wk chow or HFD fed; scale bar = 100 µ m. (B) mRNA levels of Wnt-related genes in WT and DKK1-KO HepG2 cells treated with FFA or BSA for 24 h (n = 3). (C) Representative Western blot of ROCK1, total and phosphorylated JNK in WT, and DKK1-KO HepG2 cells treated with FFA or BSA for 24 h (N = 2). * P < 0.05, ** P < 0.01 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Staining, Western Blot, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A, B, C, D, E, F, G, H) The targeted locus of DKK1 and sequencing analysis of homozygous knockout HepG2 and AML12 (A, B) cells that were confirmed with Western blot (C, D), and the paralleled experiments performed on CD36 knockout cells (E, F, G, H). (I, J, K) The DKK1-overexpressed (OE-DKK1) or DKK1-knock-down cell lines (sh-DKK1) were constructed by transfecting overexpression lentivirus or shRNA lentivirus, respectively. Scale bar = 200 µ m (I), and the DKK1 levels were confirmed by Western blot analysis (J, K). Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Sequencing, Knock-Out, Western Blot, Knockdown, Construct, Over Expression, shRNA

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A, B, C) Under DKK1 knockout conditions, cell steatosis was induced by FFA (A, B, C), n = 3 in each group. (A, B, C) Oil red O staining (A) scale bar = 50 µ m; TG measurements in DKK1 −/− AML12 (B) and DKK1 −/− HepG2 (C) cells. n = 3 in each group. (D, E) The changed TG was further confirmed with administration of a DKK1 inhibitor, WAY262611 in AML12 (D) and HepG2 (E) cells. n = 3 in each group. (F, G, H) On other hand, under DKK1 overexpression condition, the induced steatosis status was parallel analyzed, oil red O staining (F), and TG measurements in DKK1 −/− AML12 (G) and DKK1 −/− HepG2 (H) cells. n = 3 in each group. (I, J) Furthermore, the changed trend of TG was further confirmed with administration of recombinant DKK1 protein in AML12 (I) and HepG2 (J) cells. n = 3 in each group. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Knock-Out, Staining, Over Expression, Recombinant, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A, B) Volcano map (A) and KEGG analysis (B) of up- and down-regulated genes in LV-OE-DKK1 AML12 cells compared with LV-GFP-NC AML12 cells under FFA exposure for 24 h. (C, D, E, F) The expression confirmations of lipid metabolism–related genes in cell lines with different DKK1 gene manipulations under FFA treatment; DKK1 overexpression in AML12 (C) and HepG2 (D); DKK1 knockout AML12 (E) and HepG2 (F) cells. n = 3 in each group. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. ns, not significant. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Expressing, Over Expression, Knock-Out, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A, B) Representative Western blot analyses of lipid metabolism–related proteins in DKK1 overexpression- or knock-down mice (A) and DKK1 overexpression in AML12 cell line (B), in which the numbers marked above the controls were the ratio between CD36 compared with the β-Tubulin. (C, D, E, F) The ORO staining of WT and CD36 −/− cells cultured with recombinant DKK1 protein (r-hDKK1 or r-mDKK1) with or without FFA induction (C, D) scale bar = 100 µ m, and measurement of TG contents in CD36 −/− HepG2 (E) and CD36 −/− AML12 (F) cells. n = 3 in each group. (G) The CD36-promoter-driven luciferase reporter assay under DKK1 overexpression condition. n = 3 in each group. (H) Western blot analysis shows the overexpression of DKK1 increased pERK and nucleus PPARγ in AML12 cells with independent duplicates. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Western Blot, Over Expression, Knockdown, Staining, Cell Culture, Recombinant, Luciferase, Reporter Assay, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: (A, B) The GTT (A) and ITT (B) analyses of mice with treatments of AAV-GFP-NC, AAV-OE-DKK1, or AAV-sh-DKK1 and HFD-fed 20 wk (n = 3). (C) Western blot analyses of phosphorylated JNK in AML12 cells under rDKK1 stimulation (N = 2). (D) Representative Western blot analyses of phosphorylated AKT and FOXO1 in AML12 cells under insulin and rDKK1 stimulation (N = 2). * P < 0.05, ** P < 0.01, *** P < 0.001 as compared with the indicated controls by two-tailed t tests. All data are shown as the means ± SD. Source data are available for this figure.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Western Blot, Two Tailed Test

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: In response to continuous challenge with HFD, (1) the DKK1 expression is mainly induced in hepatocytes and the increased serum DKK1 could have served as a diagnostic bio-marker for steatohepatitis progression. (2) DKK1 enhances hepatic CD36 expression by activating ERK-PPARγ signaling and consequently leads to increased hepatic fatty acid uptake and hepatocyte steatosis. (3) DKK1 activates JNK to decrease the phosphorylation of AKT and FOXO1, leading to insulin resistance. Hepatic fatty acid uptake and insulin resistance synergistically exacerbate fatty acid accumulation and the resultant hepatic steatosis.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Expressing, Diagnostic Assay, Marker, Phospho-proteomics

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: List of primers used for DKK1 and CD36 knock out and identify.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Knock-Out, Sequencing

Journal: Life Science Alliance

Article Title: Hepatic DKK1-driven steatosis is CD36 dependent

doi: 10.26508/lsa.202201665

Figure Lengend Snippet: Antibodies used for Western blot and IHC.

Article Snippet: ALT, AST, TC, TG levels were measured using an automatic biochemical analyzer (7020; Hitachi) in Fengrui Biotechnology Co. Serum levels of DKK1 were measured using a commercially available mouse ELISA kit (EK0925; Boster Biological) according to the manufacturer’s instructions.

Techniques: Western Blot

Journal: Cells

Article Title: Comparison of Differentiation Pattern and WNT/SHH Signaling in Pluripotent Stem Cells Cultured under Different Conditions

doi: 10.3390/cells10102743

Figure Lengend Snippet: Analysis of ESC differentiation in medium supplemented either with FCS or SR after modification of either canonical or noncanonical WNT pathway. ( A ) Expression of germ layer markers in control or IWR-1-treated EBs. ( B ) Expression of germ layer markers in control or SP600125-treated EBs. ( C ) Expression of germ layer markers in control or siRNA-transfected EBs. ( D ) Expression of germ layer markers in control or CHIR-treated EBs. β-actin was used as a reference gene. RQ = 1 for the expression level detected in a 13.5-day-old mouse embryo. The average ΔCq for reference sample is shown on each graph. Data presented as means of three independent experiments with standard deviations; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: To inhibit secretion of all WNTs or block either canonical or noncanonical WNT pathway EBs were cultured either in medium supplemented with 15% SR or 15% ESC-qualified FCS in the presence of either 5 μM IWP-2 (inhibitor of WNT secretion; Stem Cell Technologies, Vancouver, Canada), or 5 μM IWR-1 (canonical WNT pathway inhibitor; Stem Cell Technologies) or SP600125 (noncanonical WNT pathway inhibitor, JNK inhibitor; Stem Cell Technologies) for 2, 5 or 7 days.

Techniques: Modification, Expressing, Control, Transfection

Journal: Experimental and Therapeutic Medicine

Article Title: Aged garlic extract enhances the production of β‑defensin 4 via activation of the Wnt/β‑catenin pathway in mouse gingiva

doi: 10.3892/etm.2024.12791

Figure Lengend Snippet: Effect of AGE on the β-defensin 4 production and canonical Wnt pathway in GE1 mouse gingival epithelial cells. (A) Cells were treated with AGE at the indicated concentrations (0.25-2 mg/ml) for 24 h. The amount of β-defensin 4 protein secreted into the culture medium was determined using an ELISA. The graph shows the concentration of β-defensin 4 in the medium. Data are presented as the mean ± standard deviation (n=6). * P<0.05 (Dunnett's test). (B) Cells were treated with AGE (2 mg/ml) for the indicated duration (1-24 h). The protein level of β-catenin in the nucleus was analyzed by western blotting. Images show representative data of western blotting for β-catenin with lamin B1 as the internal control. The graph shows the level of β-catenin protein normalized to that of lamin B1. Data are presented as the mean ± standard deviation (n=3-7). * P<0.05 (Mann-Whitney U test). (C) Cells were treated with AGE for 24 h in the presence or absence of LF3 (30 µM; 30-min pretreatment), an inhibitor of β-catenin in the canonical Wnt pathway. The amount of β-defensin 4 protein secreted into the culture medium was determined using an ELISA. The graph shows the concentration of β-defensin 4 in the medium. Data are presented as the mean ± standard deviation (n=4). * P<0.05, ** P<0.01 (Holm-Bonferroni test). A, AGE; AGE, aged garlic extract; C, control.

Article Snippet: A canonical Wnt signaling pathway specific inhibitor LF3 and a glycogen synthase kinase-3 (GSK-3) specific inhibitor 6-bromoindirubin-3'-oxime (BIO) were from Cayman Chemical (Ann Arbor).

Techniques: Enzyme-linked Immunosorbent Assay, Concentration Assay, Standard Deviation, Western Blot, Control, MANN-WHITNEY